| Mohamad Ahmad Younes, MD | |
|
400 Patroon Creek Blvd Ste 1, Albany, NY 12206-5014 | |
| (518) 489-0044 | |
| (518) 489-3591 |
| Full Name | Mohamad Ahmad Younes |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 400 Patroon Creek Blvd Ste 1, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366635047 | NPI | - | NPPES |
| 04846517 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 289019 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospice, Inc, The | Rensselaer, NY | Hospice |
| Albany Medical Center Hospital | Albany, NY | Hospital |
| St Peter's Hospital | Albany, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York Oncology Hematology Pc | 3072406222 | 72 |
News Archive
Bone chilling temperatures have gripped much of the country, and the American Red Cross urges everyone to be safe and prepare as much as possible.
A study aiming to develop a new therapeutic technique could bring a revolution in our approach to treating rare, fatal Sanfilippo syndrome, a disorder that affects children as young as 2 years old and leads to childhood dementia and premature death.
JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today its alignment with an innovative scientific approach of Janssen Research & Development, LLC (Janssen) and the company's Disease Interception Accelerator (DIA) group, which will focus on transforming type 1 diabetes through its disease interception strategy.
A novel compound that targets an important brain receptor has a dramatic effect against a host of cocaine addiction behaviors, including relapse behavior, a University at Buffalo animal study has found.
› Verified 3 days ago
| Entity Name | New York Oncology Hematology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609863448 PECOS PAC ID: 3072406222 Enrollment ID: O20040203000652 |
News Archive
Bone chilling temperatures have gripped much of the country, and the American Red Cross urges everyone to be safe and prepare as much as possible.
A study aiming to develop a new therapeutic technique could bring a revolution in our approach to treating rare, fatal Sanfilippo syndrome, a disorder that affects children as young as 2 years old and leads to childhood dementia and premature death.
JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today its alignment with an innovative scientific approach of Janssen Research & Development, LLC (Janssen) and the company's Disease Interception Accelerator (DIA) group, which will focus on transforming type 1 diabetes through its disease interception strategy.
A novel compound that targets an important brain receptor has a dramatic effect against a host of cocaine addiction behaviors, including relapse behavior, a University at Buffalo animal study has found.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohamad Ahmad Younes, MD 400 Patroon Creek Blvd Ste 1, Albany, NY 12206-5014 Ph: (518) 489-0044 | Mohamad Ahmad Younes, MD 400 Patroon Creek Blvd Ste 1, Albany, NY 12206-5014 Ph: (518) 489-0044 |
News Archive
Bone chilling temperatures have gripped much of the country, and the American Red Cross urges everyone to be safe and prepare as much as possible.
A study aiming to develop a new therapeutic technique could bring a revolution in our approach to treating rare, fatal Sanfilippo syndrome, a disorder that affects children as young as 2 years old and leads to childhood dementia and premature death.
JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research, announced today its alignment with an innovative scientific approach of Janssen Research & Development, LLC (Janssen) and the company's Disease Interception Accelerator (DIA) group, which will focus on transforming type 1 diabetes through its disease interception strategy.
A novel compound that targets an important brain receptor has a dramatic effect against a host of cocaine addiction behaviors, including relapse behavior, a University at Buffalo animal study has found.
› Verified 3 days ago
Arunima Rajbhandary, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 | |
Dr. Rahul Ravilla, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 43 New Scotland Ave Ste 7, Albany, NY 12208 Phone: 518-262-6696 Fax: 518-262-2624 | |
Emmanuelle Cordero Torres, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave Dept Of Nephrology, Albany Medical Center, Albany, NY 12208 Phone: 518-262-5377 | |
Nancy Shrestha, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5 Palisades Dr Ste 200, Albany, NY 12205 Phone: 518-471-3636 Fax: 518-471-3668 | |
Stephen Hillinger, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 400 Patroon Creek Blvd, Suite 1, Albany, NY 12206 Phone: 518-489-0044 Fax: 518-489-3591 | |
Louis H Gold, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Palisades Dr, Ste100, Albany, NY 12205 Phone: 518-438-4496 | |
Sean Joseph Sheehan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave, Suite 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 |